Sofinnova Ventures

AI artificial intelligence drug development computational biology machine learning

Excelsior nabs $95M to advance AI chemical synthesis aims

The funding haul includes a $70 million series A round that was co-led by Deerfield, Khosla Ventures and Sofinnova Partners, Excelsior said Wednesday.

Fraiser Kansteiner Dec 3, 2025 10:00am